Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gastrointestinal 1CNS 1Breast 1

Conditions

Breast Neoplasms 11Colorectal Neoplasms 6Prostatic Neoplasms 5Ovarian Neoplasms 5Endometrial Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Brain Neoplasms 3Urogenital Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Neoplasms, Unknown Primary 2Hereditary Breast and Ovarian Cancer Syndrome 2Head and Neck Neoplasms 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Wilms Tumor 1Squamous Cell Carcinoma of Head and Neck 1Pyloric Stenosis, Hypertrophic 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Ductal Adenocarcinoma 1Neurofibromatosis 1 1Neoplastic Syndromes, Hereditary 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lipodystrophy, Familial Partial 1Leukemia, Myeloid, Acute 1

Interventions

Cisplatin 252Radiotherapy 176Cetuximab 144pembrolizumab 120Docetaxel 96Fluorouracil 92Carboplatin 80Paclitaxel 77Radiotherapy, Intensity-Modulated 69Nivolumab 37Radiation 30Drug Therapy 30Erlotinib Hydrochloride 26Gemcitabine 25Gefitinib 21Cyclophosphamide 21Surveys and Questionnaires 20Surgical Procedures, Operative 19Standard of Care 19Pemetrexed 19durvalumab 18Magnetic Resonance Spectroscopy 17Capecitabine 17Radiosurgery 16Celecoxib 16atezolizumab 15Filgrastim 15Amifostine 15Low-Level Light Therapy 14Everolimus 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Head and Neck Neoplasms × Genetic Testing × Clear all
NCT04456140 2023-07-24

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Mayo Clinic

Phase 1 Completed
230 enrolled
BreastCNSGastrointestinalHead & Neck

Brain Neoplasms, Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Urogenital Neoplasms, Central Nervous System Neoplasms

NCT00646659 2018-07-09

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
47 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡